Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-5505Fax+1 214-645-5640- Is this information wrong?
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 2000
- University of Texas Southwestern Medical SchoolClass of 1996
Certifications & Licensure
- CA State Medical License 2002 - Present
- TX State Medical License 2000 - 2024
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan Start of enrollment: 2009 Jan 01
- Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension Start of enrollment: 2009 Sep 01
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S...> ;The Lancet. Respiratory Medicine. 2024 May 2
- 2 citationsRandomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.Grünig, E., Jansa, P., Fan, F., Hauser, J., Pannaux, M., Morganti, A., Rofael, H., Chin, K.> ;Journal of the American College of Cardiology. 2024 Jan 30
- Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies.Kim, N., MacDonald, G., Martin, N., Rosenberg, D., Solonets, M., Chin, K., McLaughlin, V., DuBrock, H., Restrepo-Jaramillo, R., Safdar, Z., Channick, R.> ;Pulmonary Therapy. 2024 Mar 1
- Join now to see all
Hospital Affiliations
- University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: